304 related articles for article (PubMed ID: 35095478)
1. Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis.
Ogonowski N; Salcidua S; Leon T; Chamorro-Veloso N; Valls C; Avalos C; Bisquertt A; Rentería ME; Orellana P; Duran-Aniotz C
Front Aging Neurosci; 2021; 13():807764. PubMed ID: 35095478
[TBL] [Abstract][Full Text] [Related]
2. MiRNA -483-5p as a Potential Noninvasive Biomarker for Early Detection of Alzheimer's Disease.
Sabry R; El Sharkawy RE; Gad NM
Egypt J Immunol; 2020 Jun; 27(2):59-72. PubMed ID: 33548978
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
[TBL] [Abstract][Full Text] [Related]
4. Psychometric Properties of the Persian Montreal Cognitive Assessment in Mild Cognitive Impairment and Alzheimer Disease.
Rashedi V; Foroughan M; Chehrehnegar N
Dement Geriatr Cogn Dis Extra; 2021; 11(1):51-57. PubMed ID: 33976692
[TBL] [Abstract][Full Text] [Related]
5. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer's Disease (AD) in the elderly?
Pinto TCC; Machado L; Bulgacov TM; Rodrigues-Júnior AL; Costa MLG; Ximenes RCC; Sougey EB
Int Psychogeriatr; 2019 Apr; 31(4):491-504. PubMed ID: 30426911
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.
Wu HZ; Ong KL; Seeher K; Armstrong NJ; Thalamuthu A; Brodaty H; Sachdev P; Mather K
J Alzheimers Dis; 2016; 49(3):755-66. PubMed ID: 26484928
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Alzheimers Res Ther; 2020 Dec; 12(1):163. PubMed ID: 33278902
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-Related microRNAs-146a and -155 Are Upregulated in Mild Cognitive Impairment Subjects Among Older Age Population in Montenegro.
Rovčanin Dragović I; Popović N; Ždralević M; Radulović L; Vuković T; Marzano F; Tullo A; Radunović M
J Alzheimers Dis; 2022; 90(2):625-638. PubMed ID: 36155522
[TBL] [Abstract][Full Text] [Related]
9. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
[TBL] [Abstract][Full Text] [Related]
10. A Hierarchical Bayesian Latent Class Model for the Diagnostic Performance of Mini-Mental State Examination and Montreal Cognitive Assessment in Screening Mild Cognitive Impairment Due to Alzheimer's Disease.
Wang X; Li F; Zhu H; Jiang Z; Niu G; Gao Q
J Prev Alzheimers Dis; 2022; 9(4):589-600. PubMed ID: 36281663
[TBL] [Abstract][Full Text] [Related]
11. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
[TBL] [Abstract][Full Text] [Related]
12. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
[TBL] [Abstract][Full Text] [Related]
13. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
[TBL] [Abstract][Full Text] [Related]
14. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
[TBL] [Abstract][Full Text] [Related]
15. Platelet Total PLA
Balietti M; Casoli T; Giacconi R; Giuli C
Rejuvenation Res; 2022 Feb; 25(1):16-24. PubMed ID: 34913745
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs and mild cognitive impairment: A systematic review.
Piscopo P; Lacorte E; Feligioni M; Mayer F; Crestini A; Piccolo L; Bacigalupo I; Filareti M; Ficulle E; Confaloni A; Vanacore N; Corbo M
Ageing Res Rev; 2019 Mar; 50():131-141. PubMed ID: 30472218
[TBL] [Abstract][Full Text] [Related]
17. Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects.
Nagaraj S; Laskowska-Kaszub K; Dębski KJ; Wojsiat J; Dąbrowski M; Gabryelewicz T; Kuźnicki J; Wojda U
Oncotarget; 2017 Mar; 8(10):16122-16143. PubMed ID: 28179587
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's Disease Blood Biomarkers Associated With Neuroinflammation as Therapeutic Targets for Early Personalized Intervention.
Oh SL; Zhou M; Chin EWM; Amarnath G; Cheah CH; Ng KP; Kandiah N; Goh ELK; Chiam KH
Front Digit Health; 2022; 4():875895. PubMed ID: 35899035
[TBL] [Abstract][Full Text] [Related]
19. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
